Get the Stockscreener App
85.81
0.47%
0.40
Solventum Corp stock is traded at $85.81, with a volume of 964.73K.
It is up +0.47% in the last 24 hours and down -4.12% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$85.41
Open:
$85.68
24h Volume:
964.73K
Relative Volume:
0.95
Market Cap:
$14.61B
Revenue:
$8.28B
Net Income/Loss:
$1.43B
P/E Ratio:
10.51
EPS:
8.1642
Net Cash Flow:
$-203.00M
1W Performance:
+0.89%
1M Performance:
-4.12%
6M Performance:
+25.23%
1Y Performance:
+20.11%
1-Day Range:
$85.68
$87.56
1-Week Range:
$84.81
$87.87
52-Week Range:
$62.38
$94.16
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
85.81 | 14.61B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
451.63 | 159.55B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
196.39 | 53.49B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
253.20 | 35.61B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
69.99 | 33.83B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.69 | 29.56B | 29.14B | 1.07B | 1.05B | 1.1956 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-26 | Upgrade | UBS | Neutral → Buy |
| Jul-09-26 | Initiated | BMO Capital Markets | Market Perform |
| May-15-26 | Initiated | Wedbush | Outperform |
| May-14-26 | Downgrade | UBS | Buy → Neutral |
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy - Zacks Investment Research
Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum’s FDA Nod Combines Tissue Scaffold with Negative Pressure Therapy - Medical Product Outsourcing
Solventum schedules November 5 results: Solventum stock has USD 14.5 billion value - ad-hoc-news.de
Solventum Corp (KB7.MU) recent insider transactions - Yahoo Finance UK
Solventum gets FDA clearance for combined wound care therapy - Investing.com
FDA clears two wound treatments for combined use, which may allow fewer dressing changes. - Stock Titan
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy* - Yahoo Finance
USU83448AC13 Bond Profile: Coupon and Redemption - TradingView
SOLN5759602 Bond Profile: Coupon and Redemption - TradingView
Precision Trading with Solventum Corporation When-issued (SOLV) Risk Zones - Stock Traders Daily
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
SOLN5759824 Bond Profile: Coupon and Redemption - TradingView
SOLN5957968 Bond Profile: Coupon and Redemption - TradingView
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 - www.marketscreener.com
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 - Yahoo Finance
At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results. - Stock Titan
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
SOLN5759603 Bond Profile: Coupon and Redemption - TradingView
SOLN5759819 Bond Profile: Coupon and Redemption - TradingView
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
SOLN5759814 Bond Profile: Coupon and Redemption - TradingView
SOLN5759818 Bond Profile: Coupon and Redemption - TradingView
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
SOLV: Solventum Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
China Sterilization Equipment Market Outlook to 2033Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities - GlobeNewswire Inc.
China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? - Zacks Investment Research
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
Why Solventum (SOLV) is a Top Value Stock for the Long-Term - Zacks Investment Research
Jefferies cuts Solventum stock price target to $34 on de-rating - Investing.com UK
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Bair Hugger warming system wins Coolest Thing Made in Minnesota award - The Business Journals
US83444MAQ42 Bond Yield and Price — BONDSCOM:US83444MAQ42 - TradingView
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why. - GlobeNewswire
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
Rothschild & Co Redburn Adjusts Price Target on Solventum to $75 From $70, Maintains Sell Rating - Yahoo Finance
Solventum Corporation (SOLV) Stock Forecasts - Yahoo Finance
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names - Zacks Investment Research
SOLN5957384 Bond Profile: Coupon and Redemption - TradingView
SOLN5957404 Bond Profile: Coupon and Redemption - TradingView
Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Australia
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
SOLN5759822 Bond Profile: Coupon and Redemption - TradingView
ETFs Investing in Solventum Corporation Stocks - TradingView
How Is Solventum's Stock Performance Compared to Other Healthcare Stocks - Barchart.com
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Solventum Corp Stock (SOLV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McMillan Wayde D. | Chief Financial Officer |
May 13 '26 |
Option Exercise |
0.00 |
9,503 |
0 |
53,041 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '26 |
Option Exercise |
0.00 |
3,960 |
0 |
22,130 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '26 |
Option Exercise |
0.00 |
2,376 |
0 |
7,632 |
| Kirberger Marcela A. | Chief Legal Affairs Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,488 |
0 |
15,492 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '26 |
Option Exercise |
0.00 |
34,315 |
0 |
158,225 |
| Landucci Amy | Chief Information Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,422 |
0 |
41,905 |
| Wendell Amy McBride | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
10,422 |
| WEILAND JOHN H | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
| Mily Elizabeth | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
9,009 |
| Wilson Darryl L. | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
0.04%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):